Clinical Trials - Phase III
Filter News
Found 22,550 articles
-
Perle Bioscience Release: Insulin Independence Revolutionary Phase 3 Trial
6/24/2015
-
Celator Pharmaceuticals, Inc. Announces Positive Induction Response Results From Phase 3 Study Of CPX-351 In Patients With High-Risk (Secondary) Acute Myeloid Leukemia
6/24/2015
-
Novo Nordisk A/S Release: In A Phase 3 Trial, Novoeight(Antihemophilic Factor [Recombinant]) Provided Long-Term Efficacy And Safety In The Prophylaxis And Treatment Of Bleeds In People With Hemophilia A
6/24/2015
-
Nuvo Research Inc. Provides Update On International Licensing Of Pennsaid 2%
6/24/2015
-
Transition Therapeutics Inc. Announces Results Of Clinical Study Of ELND005 In Agitation And Aggression In Patients With Alzheimer's Disease
6/24/2015
-
CSL Behring Announces Pivotal Data Of Novel rVIII-SingleChain Therapy In Adolescents And Adults With Hemophilia A
6/24/2015
-
Tokai Pharmaceuticals Announces Initiation Of Phase 3 ARMOR3-SV Trial Of Galeterone In AR-V7 Positive Metastatic Castration-Resistant Prostate Cancer
6/24/2015
-
GlycoMimetics, Inc. To Receive $20 Million Payment From Pfizer Following Initiation Of Phase III Trial With Rivipansel
6/24/2015
-
Amgen Brings in More Good News on Phase III Cancer Trial
6/23/2015
-
DURECT Corporation Announces Plans For A New POSIDUR (SABER-Bupivacaine) Clinical Trial
6/23/2015
-
Synta Announces Journal Publication Describing Complementary Activity Of Hsp90 Inhibition And Immune Checkpoint Blockade For Cancer Therapy
6/23/2015
-
Pfizer Announces Enrollment Of First Patient In Phase 3 Trial In Sickle Cell Disease
6/23/2015
-
Caladrius Biosciences Announces First Patient Dosed In Phase 3 Immunotherapy Trial For Melanoma
6/23/2015
-
Paratek Pharmaceuticals, Inc. Doses First Patient In Phase 3 Clinical Trial Of Omadacycline In Acute Bacterial Skin And Skin Structure Infections
6/23/2015
-
Intra-Cellular Therapies, Inc. Reports Initiation Of Randomization For ITI-007-302 Phase 3 Trial In Schizophrenia
6/23/2015
-
Synergy Pharma Initiates Second Phase 3 Clinical Trial Of Plecanatide In Patients With Irritable Bowel Syndrome With Constipation
6/23/2015
-
FORUM Pharma Snags Fast Track Status for Encenicline to Treat Cognitive Impairment in Schizophrenia
6/22/2015
-
Boehringer Ingelheim Phase III Pradax Anticoagulant Antidote Study Meets Primary Endpoints
6/22/2015
-
Resverlogix Officially Attains Phase 3 Status With A European Regulatory Authority
6/22/2015
-
Ampio Pharmaceuticals, Inc. Announces Additional Statistically Significant Study Results For Optina In The Treatment Of Diabetic Macular Edema (DME)
6/22/2015